Normal Aging Brain

  • Serge Weis
  • Michael Sonnberger
  • Andreas Dunzinger
  • Eva Voglmayr
  • Martin Aichholzer
  • Raimund Kleiser
  • Peter Strasser


While aging is seen as progressive deteriorative changes, during the adult period of life, which underlie an increasing vulnerability to challenges and thereby decrease the ability of the organism to survive, successful aging refers to physical, mental, and social well-being in older age.

Normal aging is associated with a reduction in brain weight, signs of minimal to moderate atrophy of the cerebral cortex, reduction in the volume of telencephalic lobes and white matter, and a minimal to moderate enlargement of the ventricular system.

Incidental white matter changes are a common finding on magnetic resonance imaging (MRI) of the brain in elderly persons. They are described as periventricular, deep, and subcortical signal abnormalities. Caps/lining and punctate deep subcortical white matter lesions are by far the most common signal changes in elderly subjects and occur in more than half of asymptomatic persons even in age groups below 55 years. White matter lesions affect executive functions, abstract reasoning, and motor function.

Pathways active in normal brain aging include genes for successful aging, sirtuins, telomeres, oxidative stress, inadequate repair of damage, dysregulation of cell number, stress response, inflammation, signaling cascades, synaptic transmission, axon guidance, calcium signaling, protein synthesis, translocator protein (TSPO), cathepsins, ghrelin, klotho, iron, and insulin. Genes involved in aging processes are concerned with maintenance of cholesterol, lipid or lipoprotein levels, cytokines, drug metabolism, and insulin signaling.

Treatment includes the maintenance of a healthy life style and stabilization of atherosclerosis, diabetes mellitus, hypertonus, and hyperlipidemia. Successful aging tends to be more dependent on behavior, attitude, and environment.

Selected References

  1. Akintola AA, van Heemst D (2015) Insulin, aging, and the brain: mechanisms and implications. Front Endocrinol 6:13. Scholar
  2. Amitani M, Amitani H, Cheng KC, Kairupan TS, Sameshima N, Shimoshikiryo I, Mizuma K, Rokot NT, Nerome Y, Owaki T, Asakawa A, Inui A (2017) The role of ghrelin and ghrelin signaling in aging. Int J Mol Sci 18(7):1511. Scholar
  3. Apple DM, Solano-Fonseca R, Kokovay E (2017) Neurogenesis in the aging brain. Clin Epigenetics 141:77–85. Scholar
  4. Baranowska-Bik A, Bik W (2017) Insulin and brain aging. Prz Menopauzalny 16(2):44–46. Scholar
  5. Barzilai A, Schumacher B, Shiloh Y (2017) Genome instability: linking ageing and brain degeneration. Mech Ageing Dev 161(Pt A):4–18. Scholar
  6. Boccardi V, Comanducci C, Baroni M, Mecocci P (2017) Of energy and entropy: the ineluctable impact of aging in old age dementia. Int J Mol Sci 18(12).
  7. Boksha IS, Prokhorova TA, Savushkina OK, Tereshkina EB (2017) Klotho protein: its role in aging and central nervous system pathology. Biochem Biokhim 82(9):990–1005. Scholar
  8. Cacabelos R, Torrellas C (2015) Epigenetics of aging and Alzheimer’s disease: implications for pharmacogenomics and drug response. Int J Mol Sci 16(12):30483–30543. Scholar
  9. Chandran R, Kumar M, Kesavan L, Jacob RS, Gunasekaran S, Lakshmi S, Sadasivan C, Omkumar RV (2017) Cellular calcium signaling in the aging brain. J Chem Neuroanat 95:95–114. Scholar
  10. Chow HM, Herrup K (2015) Genomic integrity and the ageing brain. Nat Rev Neurosci 16(11):672–684. Scholar
  11. Danka Mohammed CP, Park JS, Nam HG, Kim K (2017) MicroRNAs in brain aging. Mech Ageing Dev 168:3–9. Scholar
  12. Davis PC, Mirra SS, Alazraki N (1994) The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol 162(6):1267–1278. Scholar
  13. Delgado-Morales R, Agis-Balboa RC, Esteller M, Berdasco M (2017) Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. Clin Epigenet 9:67. Scholar
  14. Fenech M (2017) Vitamins associated with brain aging, mild cognitive impairment, and Alzheimer disease: biomarkers, epidemiological and experimental evidence, plausible mechanisms, and knowledge gaps. Adv Nutr 8(6):958–970. Scholar
  15. Fidaleo M, Cavallucci V, Pani G (2017) Nutrients, neurogenesis and brain ageing: from disease mechanisms to therapeutic opportunities. Biochem Pharmacol 141:63–76. Scholar
  16. Fraser MA, Shaw ME, Cherbuin N (2015) A systematic review and meta-analysis of longitudinal hippocampal atrophy in healthy human ageing. Neuroimage 112:364–374. Scholar
  17. Frater J, Lie D, Bartlett P, McGrath JJ (2017) Insulin-like growth factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: a review. Ageing Res Rev 42:14–27. Scholar
  18. Freitas HR, Ferreira GDC, Trevenzoli IH, Oliveira KJ, de Melo Reis RA (2017) Fatty acids, antioxidants and physical activity in brain aging. Nutrients 9(11).
  19. Frimat M, Daroux M, Litke R, Neviere R, Tessier FJ, Boulanger E (2017) Kidney, heart and brain: three organs targeted by ageing and glycation. Clin Sci (Lond) 131(11):1069–1092. Scholar
  20. Galluzzi S, Beltramello A, Filippi M, Frisoni GB (2008) Aging Neurol Sci 29(Suppl 3):296–300. Scholar
  21. Grimm A, Eckert A (2017) Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143(4):418–431. Scholar
  22. Hachinski VC, Potter P, Merskey H (1986) Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 13(4 Suppl):533–534Google Scholar
  23. Hachinski VC, Potter P, Merskey H (1987) Leuko-araiosis. Arch Neurol 44(1):21–23Google Scholar
  24. Ingram T, Chakrabarti L (2016) Proteomic profiling of mitochondria: what does it tell us about the ageing brain? Aging 8(12):3161–3179. Scholar
  25. Jesko H, Wencel P, Strosznajder RP, Strosznajder JB (2017) Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res 42(3):876–890. Scholar
  26. Kelly MP (2017) Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain. Cell Signal 42:281–291. Scholar
  27. Koellhoffer EC, McCullough LD, Ritzel RM (2017) Old maids: aging and its impact on microglia function. Int J Mol Sci 18(4).
  28. Kuehn E, Perez-Lopez MB, Diersch N, Dohler J, Wolbers T, Riemer M (2017) Embodiment in the aging mind. Neurosci Biobehav Rev 86:207–225. Scholar
  29. Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HW, Mastroeni D, Coleman P, Lemere CA, Hof PR, van den Hove DL, Rutten BP (2015) The epigenetics of aging and neurodegeneration. Prog Neurobiol 131:21–64. Scholar
  30. Liu H, Yang Y, Xia Y, Zhu W, Leak RK, Wei Z, Wang J, Hu X (2017) Aging of cerebral white matter. Ageing Res Rev 34:64–76. Scholar
  31. Lockhart SN, DeCarli C (2014) Structural imaging measures of brain aging. Neuropsychol Rev 24(3):271–289. Scholar
  32. Lopez-Leon M, Outeiro TF, Goya RG (2017) Cell reprogramming: therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Res Rev 40:168–181. Scholar
  33. Machiela MJ, Chanock SJ (2017) The ageing genome, clonal mosaicism and chronic disease. Curr Opin Genet Dev 42:8–13. Scholar
  34. Maes C, Gooijers J, Orban de Xivry JJ, Swinnen SP, Boisgontier MP (2017) Two hands, one brain, and aging. Neurosci Biobehav Rev 75:234–256. Scholar
  35. Martinez G, Duran-Aniotz C, Cabral-Miranda F, Vivar JP, Hetz C (2017) Endoplasmic reticulum proteostasis impairment in aging. Aging Cell 16(4):615–623. Scholar
  36. Masri S (2015) Sirtuin-dependent clock control: new advances in metabolism, aging and cancer. Curr Opin Clin Nutr Metab Care 18(6):521–527. Scholar
  37. Mather M (2016) The affective neuroscience of aging. Annu Rev Psychol 67:213–238. Scholar
  38. Matt SM, Johnson RW (2016) Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation. Curr Opin Pharmacol 26:96–101. Scholar
  39. Maynard S, Fang EF, Scheibye-Knudsen M, Croteau DL, Bohr VA (2015) DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb Perspect Med 5(10).
  40. Mohan A, Mather KA, Thalamuthu A, Baune BT, Sachdev PS (2016) Gene expression in the aging human brain: an overview. Curr Opin Psychiatry 29(2):159–167. Scholar
  41. Muller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, Casanueva FF, D’Alessio D, Depoortere I, Geliebter A, Ghigo E, Cole PA, Cowley M, Cummings DE, Dagher A, Diano S, Dickson SL, Dieguez C, Granata R, Grill HJ, Grove K, Habegger KM, Heppner K, Heiman ML, Holsen L, Holst B, Inui A, Jansson JO, Kirchner H, Korbonits M, Laferrere B, LeRoux CW, Lopez M, Morin S, Nakazato M, Nass R, Perez-Tilve D, Pfluger PT, Schwartz TW, Seeley RJ, Sleeman M, Sun Y, Sussel L, Tong J, Thorner MO, van der Lely AJ, van der Ploeg LH, Zigman JM, Kojima M, Kangawa K, Smith RG, Horvath T, Tschop MH (2015) Ghrelin. Mol Metab 4(6):437–460. Scholar
  42. Nagata K, Yamazaki T, Takano D, Maeda T, Fujimaki Y, Nakase T, Sato Y (2016) Cerebral circulation in aging. Ageing Res Rev 30:49–60. Scholar
  43. Ng F, Wijaya L, Tang BL (2015) SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci 9:64. Scholar
  44. Nyberg L (2017) Neuroimaging in aging: brain maintenance. F1000Research 6:1215. Scholar
  45. Patel R, Sesti F (2016) Oxidation of ion channels in the aging nervous system. Brain Res 1639:174–185. Scholar
  46. Plaza-Zabala A, Sierra-Torre V, Sierra A (2017) Autophagy and microglia: novel partners in neurodegeneration and aging. Int J Mol Sci 18(3).
  47. Rawji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW (2016) Immunosenescence of microglia and macrophages: impact on the ageing central nervous system. Brain 139(Pt 3):653–661. Scholar
  48. Ren R, Ocampo A, Liu GH, Izpisua Belmonte JC (2017) Regulation of stem cell aging by metabolism and epigenetics. Cell Metab 26(3):460–474. Scholar
  49. Repalli J (2014) Translocator protein (TSPO) role in aging and Alzheimer’s disease. Curr Aging Sci 7(3):168–175Google Scholar
  50. Rodriguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A (2016) Astrocytes in physiological aging and Alzheimer’s disease. Neuroscience 323:170–182. Scholar
  51. Rowe JW, Kahn RL (1987) Human aging: usual and successful. Science (New York, NY) 237(4811):143–149Google Scholar
  52. Rozycka A, Liguz-Lecznar M (2017) The space where aging acts: focus on the GABAergic synapse. Aging Cell 16(4):634–643. Scholar
  53. Satoh A, Imai SI, Guarente L (2017) The brain, sirtuins, and ageing. Nat Rev Neurosci 18(6):362–374. Scholar
  54. Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, Seiler S, Enzinger C, Ropele S, Erkinjuntti T, Pantoni L, Scheltens P, Fazekas F, Jellinger K (2011) Heterogeneity in age-related white matter changes. Acta Neuropathol 122(2):171–185. Epub 2011 Jun 2025.Google Scholar
  55. Shwe T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2017) Role of D-galactose-induced brain aging and its potential used for therapeutic interventions. Exp Gerontol 101:13–36. Scholar
  56. Stefanatos R, Sanz A (2017) The role of mitochondrial ROS in the aging brain. FEBS Lett 592(5):743–758. Scholar
  57. Stegeman R, Weake VM (2017) Transcriptional signatures of aging. J Mol Biol 429(16):2427–2437. Scholar
  58. Stoka V, Turk V, Turk B (2016) Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res Rev 32:22–37. Scholar
  59. Stoyanova II (2014) Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis 72(Pt A):72–83. Scholar
  60. Stroo E, Koopman M, Nollen EA, Mata-Cabana A (2017) Cellular regulation of amyloid formation in aging and disease. Front Neurosci 11:64. Scholar
  61. Sugiura M (2016) Functional neuroimaging of normal aging: declining brain, adapting brain. Ageing Res Rev 30:61–72. Scholar
  62. Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM (2017) Mitochondria, cybrids, aging, and Alzheimer’s disease. Prog Mol Biol Transl Sci 146:259–302. Scholar
  63. Szafranski K, Abraham KJ, Mekhail K (2015) Non-coding RNA in neural function, disease, and aging. Front Genet 6:87. Scholar
  64. Taylor RC (2016) Aging and the UPR(ER). Brain Res 1648(Pt B):588–593. Scholar
  65. Torok N, Majlath Z, Fulop F, Toldi J, Vecsei L (2016) Brain aging and disorders of the central nervous system: kynurenines and drug metabolism. Curr Drug Metab 17(5):412–429Google Scholar
  66. Van Raamsdonk JM (2017) Mechanisms underlying longevity: a genetic switch model of aging. Exp Gerontol 107:136–139. Scholar
  67. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045–1060. Scholar
  68. Xekardaki A, Kovari E, Gold G, Papadimitropoulou A, Giacobini E, Herrmann F, Giannakopoulos P, Bouras C (2015) Neuropathological changes in aging brain. Adv Exp Med Biol 821:11–17. Scholar
  69. Yin Y, Zhang W (2016) The role of ghrelin in senescence: a mini-review. Gerontology 62(2):155–162. Scholar
  70. Yu XW, Oh MM, Disterhoft JF (2017) CREB, cellular excitability, and cognition: implications for aging. Behav Brain Res 322(Pt B):206–211. Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Serge Weis
    • 1
  • Michael Sonnberger
    • 2
  • Andreas Dunzinger
    • 3
  • Eva Voglmayr
    • 2
  • Martin Aichholzer
    • 4
  • Raimund Kleiser
    • 2
  • Peter Strasser
    • 5
  1. 1.Division of Neuropathology, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  2. 2.Department of Neuroradiology, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  3. 3.Department of Neuro-Nuclear Medicine, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  4. 4.Department of Neurosurgery, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  5. 5.PMU University Institute for Medical & Chemical Laboratory DiagnosticsSalzburgAustria

Personalised recommendations